Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharyn D Baker

Showing results (71-80 of 166) with videos related to

Pageof 17
Sort By:
Clinical Pharmacology and Therapeutics|April 30, 2004
Effect of cytochrome P450 3A4 inhibition on the pharmacokinetics of docetaxelFrederike K Engels, Albert J Ten Tije, Sharyn D Baker, et al.
Journal of the National Cancer Institute|December 7, 2006
Pharmacogenetics of ABCG2 and adverse reactions to gefitinibGeorge Cusatis, Vanesa Gregorc, Jing Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Effect of milk thistle (Silybum marianum) on the pharmacokinetics of irinotecanNielka P H van Erp, Sharyn D Baker, Ming Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Interaction of imatinib with human organic ion carriersShuiying Hu, Ryan M Franke, Kelly K Filipski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Comparative pharmacokinetics of weekly and every-three-weeks docetaxelSharyn D Baker, Ming Zhao, Carlton K K Lee, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2006
Phase I study of continuous weekly dosing of dimethylamino benzoylphenylurea (BPU) in patients with solid tumoursWells A Messersmith, Michelle A Rudek, Sharyn D Baker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
A phase I and pharmacokinetic study of short infusions of UCN-01 in patients with refractory solid tumorsE Claire Dees, Sharyn D Baker, Seamus O'Reilly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Disposition of docosahexaenoic acid-paclitaxel, a novel taxane, in blood: in vitro and clinical pharmacokinetic studiesAlex Sparreboom, Antonio C Wolff, Jaap Verweij, et al.
Cancer Chemotherapy and Pharmacology|April 30, 2016
Evaluation of artemisinins for the treatment of acute myeloid leukemiaChristina D Drenberg, Jassada Buaboonnam, Shelley J Orwick, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 27, 2006
A rapid and sensitive method for determination of sorafenib in human plasma using a liquid chromatography/tandem mass spectrometry assayMing Zhao, Michelle A Rudek, Ping He, et al.
Pageof 17

Showing results (71-80 of 166) with videos related to

Sort By:
Pageof 17
Clinical Pharmacology and Therapeutics|April 30, 2004
Effect of cytochrome P450 3A4 inhibition on the pharmacokinetics of docetaxelFrederike K Engels, Albert J Ten Tije, Sharyn D Baker, et al.
Journal of the National Cancer Institute|December 7, 2006
Pharmacogenetics of ABCG2 and adverse reactions to gefitinibGeorge Cusatis, Vanesa Gregorc, Jing Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Effect of milk thistle (Silybum marianum) on the pharmacokinetics of irinotecanNielka P H van Erp, Sharyn D Baker, Ming Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Interaction of imatinib with human organic ion carriersShuiying Hu, Ryan M Franke, Kelly K Filipski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Comparative pharmacokinetics of weekly and every-three-weeks docetaxelSharyn D Baker, Ming Zhao, Carlton K K Lee, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2006
Phase I study of continuous weekly dosing of dimethylamino benzoylphenylurea (BPU) in patients with solid tumoursWells A Messersmith, Michelle A Rudek, Sharyn D Baker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
A phase I and pharmacokinetic study of short infusions of UCN-01 in patients with refractory solid tumorsE Claire Dees, Sharyn D Baker, Seamus O'Reilly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Disposition of docosahexaenoic acid-paclitaxel, a novel taxane, in blood: in vitro and clinical pharmacokinetic studiesAlex Sparreboom, Antonio C Wolff, Jaap Verweij, et al.
Cancer Chemotherapy and Pharmacology|April 30, 2016
Evaluation of artemisinins for the treatment of acute myeloid leukemiaChristina D Drenberg, Jassada Buaboonnam, Shelley J Orwick, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 27, 2006
A rapid and sensitive method for determination of sorafenib in human plasma using a liquid chromatography/tandem mass spectrometry assayMing Zhao, Michelle A Rudek, Ping He, et al.
Pageof 17